Share This

Hot News

股匯市況.不斷更新|恆指半日升208點小米績前解禁令僅微升騰訊升1.3% | 蘋果日報 @ 2021-05-26T16: Back Hot News
Keyword:騰訊 小米 股市 恆指 北水
Concept:港股市 , 小米騰訊
恆指收漲約1.8%:恆生科技指數重返八千點 騰訊、小米漲超4%
港股通連續10個交易日錄淨買入,昨淨買入78.59億元。北水尤為寵幸騰訊,10天以來淨買入累計156億元,美團(3690)、小米淨買入累計分別有73億元、近50億元。恆指夜期稍回吐,至昨晚11時半報28,861點,低水50點。
【恆指夜期+ADR】騰訊ADR收市低港1.6%失600關 北水吸資54億買小米騰訊(不斷更新)
恆指今早高開145點後,升勢持續.藍籌股個別發展,海底撈(06862)升幅最大,升百分之4.6,銀河娛樂(00027)升百分之3.3.新地(00016)升百分之2.6,港交所(00388)升百分之1.6.新經濟股造好,美團(03690)升近百分之3、騰訊(00700)升百分之1.3,小米(01810)獲美國法院正式解除投資者購買或持有公司證券全部限制,升不足百分之1、阿里巴巴(09988)升不足百分之1.阿里健康(00241)業績雖然扭虧為盈,但遜市場預期,股價早段跌逾百分6,是表現最差的藍籌.石油股遍軟,中石油(00857)跌百分之1.5、中海油(00883)跌百分之1.4,中石化(00386)跌百分之1.2
周二恆指走勢隨A股向好,高開高走,並以近高位收市,全日波幅 467.74點。恆指收報 28910.86點,升498.6點或1.75%,成交金額 1678.7億元。國指收報 10792.63點,升151.23點或1.42%;紅籌指數收報 4132.74點,升28.54點或0.7%。三項指數都向好,以恆指走勢較佳,原因是騰訊(0700)、港交所(0388)、藥明生物(2269)及小米(1810)分別升 4.184%、5.373%、5.92%及4.128%,合共為指數貢獻約720點升幅。
北水當日流入騰訊(700)及港交所(388)最多,股價分別升4%及5%。騰訊、小米集團(1810)、美團(3690)及阿里巴巴(9988)合共貢獻恆指185點。雖然快手(1024)昨績後急瀉一成無礙科技指數重上8000點關口,收升127點或1.62%。另外,將於周五掛牌的京東物流(2618),機構投資者擬先進行場外暗盤交易,出價介乎42元至44.4元,較招股價40.36元,升4.06%至10%。
騰訊(00700)、小米(01810)及藥明生物(02269)為升市火車頭,撐起恆指203點,半日分別升4.1%;4.9%和5.7%,藥明生物更是表現最佳藍籌;友邦(01299)也升1.5%;工行(01398)漲0.9%;平保(02318)漲1.5%;安踏(02020)與申洲(02313)盤中創新高,半日升3.1%和1.5%;但匯控(00005)下滑0.3%;中生制藥(01177)首季純利按年大升1.18倍,今早曾飆7.1%,半日卻倒跌3.2%,為表現最差藍籌。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.